Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS

Clinical trial NCT00232297 · COMPLETED

Trial details

NCT number: NCT00232297
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Arrhythmia Tachycardia, Ventricular Ventricular Fibrillation

Start date: 2005-06-01
Primary completion: 2007-02-01
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.